VA STARPORT

An aspect marked incomplete is a question the public commentary did not let us answer. We show it rather than hide it.

Screened window

Nov 29, 2020 → Oct 8, 2026

Cited window

Nov 29, 2020 → Oct 8, 2026

Retrieved

Oct 29, 2026

Title

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for OligoRecurrenT Prostate Cancer (VA STARPORT)

Also known as

STARPORT

Registry

NCT04787744

Study IDs

ONCA-026-20S · 1I01CX002277-01 · CX002277-01 (VA Investigators, Scientific Review and Management)

Sponsor

VA Office of Research and Development

Design

Phase 2/Phase 3 · Interventional, randomized, parallel

Status

Active, not recruiting

Enrollment

378 actual

Registered

2021-03-09

Start

2021-07-01 actual

Primary completion

2026-10-02 actual

Primary endpoint

Castration-resistant prostate cancer-free survival (CRPC-free survival)

Interventions

12 registered

This report does not judge efficacy, estimate HCP prevalence or consensus or give treatment advice.

• –Discussion that does not name the trial may be missing from this edition.
• –Some clinician views in the sources used in this report are not yet captured as evidence in this edition.
• –Some passages in the sources used in this report were not fully assessed for clinician views, so a view there may be missing from this edition.
• –61 statements in the sources reviewed for this edition are about other patients or topics, or only mention the trial, and are not counted.
• –Further source limits apply, so some matching discussion may be missing.
• –No full VA STARPORT protocol or trial-specific results publication is included. Speakers’ explanations of planned conduct, possible adaptations and expected benefit should not be treated as completed analyses or confirmed treatment effects.
• –Some potentially relevant passages were not fully assessed. Discussion that never named VA STARPORT, used alternative spellings or wording, or preceded registration may be underrepresented.
• –The reviewed public discussion does not establish the prevalence of any view among HCPs. Reposts and repeated posts are not additional independent clinical opinions.
• –Some speakers' identities or clinical roles are not established in the sources used in this report; each statement is attributed only as far as its source shows.
• –A speaker is described in the source as involved in VA STARPORT. The trial explanations and operational observations should not be counted as independent external validation.
• –Statements about other trials preserve their own populations, regimens and outcomes. In particular, breast-cancer findings, intermittent-treatment PSA observations and mixed-castration-status pooled results are not VA STARPORT results.
• –Source dates span 2020–2026. Site counts, enrollment observations, anticipated timelines and expectations of practice impact are dated statements, not confirmation of current status.
• –No exact regulatory labels for several grouped systemic-treatment options were available in the reviewed material. The report does not establish label-specific eligibility or prescribing conclusions.
• –Not yet captured in this edition: a view on metastasis-directed therapy in oligorecurrent prostate cancer and the need for stronger evidence across survival endpoints.
• –Not yet captured in this edition: a view on restricted access to PSMA PET imaging for PET-directed treatment decisions.

How reports are built and checked: Methods.

Last checked for new commentary Oct 29, 2026. A new or changed finding gets a new version number; added evidence alone is a smaller update.

Paste this into ChatGPT, Claude, Microsoft Copilot or your own agent. It previews this report through the free Erudio MCP server, tells you whether it answers your question, and orders it if you ask. Some agents ask you to confirm pasted instructions before acting; that is expected.

Help me decide whether to buy the Erudio report "VA STARPORT" (NCT04787744), and buy it for me if I ask. Erudio reports cover what clinicians say in public about one clinical trial, with every verified statement linked to its source.

1. Use the free Erudio MCP server at https://mcp.erudio.com/free; it needs no sign-in. Nothing needs installing: if it is not connected in this app and you can make HTTP requests, call it directly with JSON-RPC POSTs to that URL (initialize, then tools/call), sending "Accept: application/json, text/event-stream". Call get_report_card with slug "va-starport-04787744". If you cannot make requests, read https://www.erudio.com/reports/va-starport-nct04787744.md instead.
2. In a few lines, tell me what the report covers: its findings, its verified statements and sources, its evidence window, what it leaves out, and the price of each product (offer). Then ask what I need it for, and say plainly whether this report answers it.
3. If I want it, ask for my work email and the product: the current edition, or 3, 6 or 12 months of weekly updates. Call create_order with report "NCT04787744", that product and email, then show me the quote and the checkout_url to pay by card. If you have a payment client for HTTP 402 payments and I agree, you can pay the pay_url instead. Nothing is charged until one is paid.
4. Once it is paid, call get_order with the status_url: it returns my license key. Then use the Erudio MCP server at https://mcp.erudio.com/mcp with the header "Authorization: Bearer <key>". Call read_report with report_id erudio-nct04787744 and sections ["all"], and summarize the findings for me with their sources. The full report is large (about 500 KB): save the response to a file and work from it rather than printing it. If you cannot, read sections ["narratives"] first, the executive summary and analysis.

When you tell me what clinicians said, give each view as theirs, with its source. Counts are the sources the report kept, not the share of clinicians who agree. Reports are not medical advice.
Keep the key private to my organization.

curl https://www.erudio.com/reports/va-starport-nct04787744.json
curl https://www.erudio.com/reports/va-starport-nct04787744.md

# MCP, no sign-in (https://mcp.erudio.com/free)
get_report_card({ "slug": "va-starport-04787744" })